MOLECULAR THERAPY ONCOLOGY Journal

publication venue for

A novel combination approach targeting P300 and DNA-PK exploits epigenetic dependencies in acute myeloid leukemia. 34. 2026

Electronic International Standard Serial Number (EISSN)

2950-3299

journal abbreviation

MOL THER ONCOL